Pelthos Therapeutics Inc. (PTHS) — Institutional Holders, Q2 2026
24 institutional investment managers reported a PTHS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $37.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PTHS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- AIGH Capital ManagementNew · +329,098 sh+$9.3M
- WEXFORD CAPITALNew · +22,364 sh+$632.0K
- BOOTHBAY FUND MANAGEMENTAdded · +20,118 sh+$568.5K
- CITADEL ADVISORSNew · +15,046 sh+$425.2K
- 1492 Capital ManagementNew · +10,380 sh+$293.3K
Biggest sellers
- J. GoldmanTrimmed · -12,340 sh-$348.7K
- CANTOR FITZGERALD, L. P.Trimmed · -3,300 sh-$93.3K
- Steward Partners Investment AdvisorySold out · -1,910 sh-$54.0K
- GEODE CAPITAL MANAGEMENTTrimmed · -640 sh-$18.1K
- Aspect PartnersSold out · -16 sh-$452.00
PTHS 13F holders ranked 1–24 of 24
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | AIGH Capital Management#1 · 329,098 sh | 329,098 | $9.3M | 0.59% | New |
| 2 | Murchinson Ltd.#2 · 304,302 sh | 304,302 | $8.6M | 1.19% | +2.7% |
| 3 | Ikarian Capital#3 · 256,598 sh | 256,598 | $7.3M | 0.78% | 0.0% |
| 4 | BOOTHBAY FUND MANAGEMENT#4 · 101,976 sh | 101,976 | $2.9M | 0.04% | +24.6% |
| 5 | VANGUARD CAPITAL MANAGEMENT#5 · 97,134 sh | 97,134 | $2.7M | <0.01% | +4.3% |
| 6 | CANTOR FITZGERALD, L. P.#6 · 38,123 sh | 38,123 | $1.1M | 0.01% | -8.0% |
| 7 | J. Goldman#7 · 38,075 sh | 38,075 | $1.1M | 0.03% | -24.5% |
| 8 | DIADEMA PARTNERS#8 · 24,773 sh | 24,773 | $700.1K | 0.09% | 0.0% |
| 9 | WEXFORD CAPITAL#9 · 22,364 sh | 22,364 | $632.0K | 0.08% | New |
| 10 | Knott David M Jr#10 · 22,073 sh | 22,073 | $623.8K | 0.33% | +4.7% |
| 11 | CITADEL ADVISORS#11 · 15,046 sh | 15,046 | $425.2K | 0.00% | New |
| 12 | GEODE CAPITAL MANAGEMENT#12 · 14,650 sh | 14,650 | $414.0K | 0.00% | -4.2% |
| 13 | Pale Fire Capital SE#13 · 12,919 sh | 12,919 | $365.1K | 0.03% | 0.0% |
| 14 | 1492 Capital Management#14 · 10,380 sh | 10,380 | $293.3K | 0.09% | New |
| 15 | VANGUARD FIDUCIARY#15 · 9,873 sh | 9,873 | $279.0K | <0.01% | +0.6% |
| 16 | STATE STREET#16 · 9,800 sh | 9,800 | $276.9K | 0.00% | New |
| 17 | Persistent Asset Partners Ltd#17 · 6,007 sh | 6,007 | $169.8K | 0.05% | 0.0% |
| 18 | BlackRock#18 · 5,324 sh | 5,324 | $150.5K | 0.00% | New |
| 19 | UBS Group AG#19 · 2,217 sh | 2,217 | $62.7K | 0.00% | +190.2% |
| 20 | China Universal Asset Management , Ltd.#20 · 2,160 sh | 2,160 | $61.0K | <0.01% | New |
| 21 | Tower Research Capital (TRC)#21 · 205 sh | 205 | $5.8K | <0.01% | New |
| 22 | Farther Finance Advisors#22 · 40 sh | 40 | $1.1K | — | 0.0% |
| 23 | BARCLAYS PLC#23 · 20 sh | 20 | $565.00 | 0.00% | New |
| 24 | ROYAL BANK OF CANADA#24 · 6 sh | 6 | $0.00 | 0.00% | New |
Funds that sold out of PTHS in Q2 2026 (3)
Held PTHS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Steward Partners Investment Advisory1,910 sh | 1,910 | $40.1K |
| Aspect Partners16 sh | 16 | $336.00 |
| CITIGROUP1 sh | 1 | $21.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.